Compare OPFI & ARAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OPFI | ARAY |
|---|---|---|
| Founded | 2009 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 274.2M | 100.5M |
| IPO Year | N/A | 2007 |
| Metric | OPFI | ARAY |
|---|---|---|
| Price | $9.04 | $0.63 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $13.50 | $3.50 |
| AVG Volume (30 Days) | 527.4K | ★ 839.3K |
| Earning Date | 03-04-2026 | 02-04-2026 |
| Dividend Yield | ★ 2.76% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.14 | N/A |
| Revenue | $335,423,000.00 | ★ $436,969,000.00 |
| Revenue This Year | $120.32 | $3.82 |
| Revenue Next Year | $10.85 | $4.08 |
| P/E Ratio | $66.11 | ★ N/A |
| Revenue Growth | ★ 28.69 | N/A |
| 52 Week Low | $7.54 | $0.54 |
| 52 Week High | $17.73 | $2.95 |
| Indicator | OPFI | ARAY |
|---|---|---|
| Relative Strength Index (RSI) | 32.58 | 22.22 |
| Support Level | $8.75 | $0.56 |
| Resistance Level | $9.92 | $0.83 |
| Average True Range (ATR) | 0.33 | 0.05 |
| MACD | -0.09 | -0.01 |
| Stochastic Oscillator | 15.95 | 17.06 |
OppFi Inc is a tech-enabled, mission-driven specialty finance platform that broadens the reach of community banks to extend credit access to everyday Americans. It recognizes revenue through finance charges on installment and SalaryTap contracts based on the interest method.
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.